| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242354 | Respiratory Medicine | 2014 | 25 Pages |
Abstract
Methodological limitations and lack of power of several studies prevent us to conclude on the perinatal safety of beta2-agonists. Until further evidence is available, physicians should continue prescribing them as recommended in the guidelines whenever needed to attain asthma control.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Sherif Eltonsy, Fatima-Zohra Kettani, Lucie Blais,